We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

71 hedge funds and large institutions have $12.8M invested in Ampio Pharmaceuticals Inc. in 2016 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 18 increasing their positions, 17 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more capital invested

Capital invested by funds: $8.86M → $12.8M (+$3.92M)

16% more call options, than puts

Call options by funds: $123K | Put options by funds: $106K

6% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 17

0% more funds holding

Funds holding: 71 → 71 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 9

Holders
71
Holders Change
–
Holders Change %
0%
% of All Funds
1.77%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
9
Increased
18
Reduced
17
Closed
9
Calls
$123K
Puts
$106K
Net Calls
+$17K
Net Calls Change
+$131K

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.89M
2
BFA
BlackRock Fund Advisors
California
+$290K
3
Morgan Stanley
Morgan Stanley
New York
+$106K
4
VKH
Virtu KCG Holdings
New York
+$61.9K
5
Group One Trading
Group One Trading
Illinois
+$45.5K

Top Sellers

Rank Fund Capital Flow
1
NFG
Noven Financial Group
Colorado
-$202K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$166K
3
Renaissance Technologies
Renaissance Technologies
New York
-$128K
4
SG Americas Securities
SG Americas Securities
New York
-$60K
5
Deutsche Bank
Deutsche Bank
Germany
-$51.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Cambridge Investment Research Advisors
26
Cambridge Investment Research Advisors
Iowa
$44K -$4.76K -20 -11%
New York State Common Retirement Fund
27
New York State Common Retirement Fund
New York
$40K – – –
RhumbLine Advisers
28
RhumbLine Advisers
Massachusetts
$31K -$8.57K -36 -24%
NFA
29
Nationwide Fund Advisors
Ohio
$25K – – –
Simplex Trading
30
Simplex Trading
Illinois
$24K +$16.7K +70 +333%
AG
31
Advisor Group
Arizona
$23K – – –
AIG
32
American International Group
New York
$23K – – –
GC
33
Guggenheim Capital
Illinois
$23K +$238 +1 +1%
VOYA Investment Management
34
VOYA Investment Management
Georgia
$21K – – –
Deutsche Bank
35
Deutsche Bank
Germany
$20K -$51.2K -215 -73%
Wells Fargo
36
Wells Fargo
California
$20K -$3.57K -15 -16%
Bank of America
37
Bank of America
North Carolina
$20K +$3.57K +15 +26%
BA
38
BlackRock Advisors
Delaware
$19K – – –
California Public Employees Retirement System
39
California Public Employees Retirement System
California
$18K – – –
NFG
40
Next Financial Group
Texas
$18K – – –
OWP
41
Obermeyer Wealth Partners
Colorado
$18K – – –
OC
42
Oppenheimer & Co
New York
$18K – – –
CS
43
Credit Suisse
Switzerland
$17K -$4.53K -19 -23%
JWA
44
JFS Wealth Advisors
Pennsylvania
$16K – – –
Brown Advisory
45
Brown Advisory
Maryland
$15K -$13.1K -55 -50%
RJA
46
Raymond James & Associates
Florida
$15K +$3.33K +14 +34%
JWM
47
Janiczek Wealth Management
Colorado
$15K +$13.3K +56 New
PL
48
Plancorp LLC
Missouri
$14K +$11.9K +50 New
CC
49
Courier Capital
New York
$13K -$476 -2 -4%
PNC Financial Services Group
50
PNC Financial Services Group
Pennsylvania
$12K – – –
1
2
3 4

AMPE Hedge Fund Activity: Q4 2016 in Review

71 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q4 2016, worth a combined $12.8M — up 44% from $8.86M a quarter earlier.

Fund positioning in AMPE was balanced in Q4 2016: 9 funds opened new positions, 9 closed out, 18 added to existing stakes and 17 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $1.89M. The largest seller was Noven Financial Group, cutting an estimated $202K.

  • 71 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q4 2016, unchanged from Q3 2016.
  • Funds reported $12.8M of Ampio Pharmaceuticals Inc. stock for Q4 2016, up 44% quarter-over-quarter.
  • 9 funds opened new Ampio Pharmaceuticals Inc. positions in Q4 2016 and 9 closed out, a net change of 0 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q4 2016 was Susquehanna International Group, an estimated $1.89M added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q4 2016 was Noven Financial Group, an estimated $202K sold.

Based on aggregated 13F filings for Q4 2016.